A New Treatment Paradigm for Diabetic Macular Edema
Retina Synthesis - A podcast by Retina Synthesis
Categories:
Dr. Jamie Dananberg, Chief Medical Officer of Unity Biotechnology discusses their strategy of selectively targeting senescent retinal vascular endothelial cells for a more long lasting effect on altering the pathophysiology of diabetic eye disease.
